医学
彭布罗利珠单抗
泌尿生殖系统
无容量
杜瓦卢马布
膀胱癌
免疫疗法
肿瘤科
膀胱切除术
内科学
临床试验
癌症
肾癌
疾病
佐剂
重症监护医学
作者
Andrea Necchi,Bishoy M. Faltas,Susan F. Slovin,Joshua J. Meeks,Sumanta K. Pal,Lawrence H. Schwartz,Richard S.P. Huang,Roger Li,Brandon J. Manley,Jad Chahoud,Jeffrey S. Ross,Philippe E. Spiess
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2023-08-10
卷期号:9 (10): 1447-1447
被引量:5
标识
DOI:10.1001/jamaoncol.2023.2174
摘要
A true revolution in the management of advanced genitourinary cancers has occurred with the discovery and adoption of immunotherapy (IO). The therapeutic benefits of IO were recently observed not to be solely confined to patients with disseminated disease but also in select patients with localized and locally advanced genitourinary neoplasms.
科研通智能强力驱动
Strongly Powered by AbleSci AI